Rossari Biotech Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹820.2
- Today's High:
- ₹861.4
- Open Price:
- ₹855
- 52W Low:
- ₹535.7228
- 52W High:
- ₹1050.2605
- Prev. Close:
- ₹857.25
- Volume:
- 13118
Company Statistics
- Market Cap.:
- ₹47.98 billion
- Book Value:
- 165.925
- Revenue TTM:
- ₹16.32 billion
- Operating Margin TTM:
- 9.37%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 6.61%
- Return on Assets TTM:
- 7.22%
- Return on Equity TTM:
- 12.47%
Company Profile
Rossari Biotech Limited had its IPO on under the ticker symbol ROSSARI.
The company operates in the Basic Materials sector and Specialty Chemicals industry. Rossari Biotech Limited has a staff strength of 500 employees.
Stock update
Shares of Rossari Biotech Limited opened at ₹855 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹820.2 - ₹861.4, and closed at ₹832.95.
This is a -2.83% slip from the previous day's closing price.
A total volume of 13,118 shares were traded at the close of the day’s session.
In the last one week, shares of Rossari Biotech Limited have slipped by -2.08%.
Rossari Biotech Limited's Key Ratios
Rossari Biotech Limited has a market cap of ₹47.98 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Rossari Biotech Limited’s revenue was ₹16.32 billion with a gross profit of ₹0 and an EBITDA of ₹2.19 billion. The EBITDA ratio measures Rossari Biotech Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Rossari Biotech Limited’s operating margin was 9.37% while its return on assets stood at 7.22% with a return of equity of 12.47%.
In Q1, Rossari Biotech Limited’s quarterly earnings growth was a positive 1.9% while revenue growth was a negative 5.5%.
Rossari Biotech Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 44.8428
- PEG
Its diluted EPS in the last 12-months stands at ₹19.4 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Rossari Biotech Limited’s profitability.
Rossari Biotech Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Rossari Biotech Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.06% and a payout ratio of 2.57%.
Balance sheet and cash flow metrics
- Total Assets
- ₹13.68 billion
- Total Liabilities
- ₹3.47 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 2.57%
Rossari Biotech Limited ended 2024 with ₹13.68 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹13.68 billion while shareholder equity stood at ₹9.15 billion.
Rossari Biotech Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹3.47 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹1.19 billion in goodwill. Its cash balance stood at ₹698.32 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹349.33 million.
Rossari Biotech Limited’s total current assets stands at ₹7.21 billion while long-term investments were ₹0 and short-term investments were ₹819.52 million. Its net receivables were ₹3.54 billion compared to accounts payable of ₹1.85 billion and inventory worth ₹1.88 billion.
In 2024, Rossari Biotech Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Rossari Biotech Limited paid ₹0.03 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹832.95
- 52-Week High
- ₹1050.2605
- 52-Week Low
- ₹535.7228
- Analyst Target Price
- ₹
Rossari Biotech Limited stock is currently trading at ₹832.95 per share. It touched a 52-week high of ₹1050.2605 and a 52-week low of ₹1050.2605. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹849.17 and 200-day moving average was ₹749.18 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6982.9% of the company’s stock are held by insiders while 2060.3% are held by institutions.
Frequently Asked Questions About Rossari Biotech Limited
Similar Industry Stocks (Specialty Chemicals)
Most Active
Top Gainers
Top Losers
About
Rossari Biotech Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it provides poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. The company was founded in 1997 and is based in Mumbai, India.